- Home
- RXST vs SLDB Comparison
RXST vs SLDB Comparison
Compare RXST & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- SLDB
- Stock Information
- Founded
- RXST 1997
- SLDB 2013
- Country
- RXST United States
- SLDB United States
- Employees
- RXST N/A
- SLDB N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RXST Health Care
- SLDB Health Care
- Exchange
- RXST Nasdaq
- SLDB Nasdaq
- Market Cap
- RXST 365.8M
- SLDB 433.0M
- IPO Year
- RXST 2021
- SLDB 2018
- Fundamental
- Price
- RXST $9.13
- SLDB $5.45
- Analyst Decision
- RXST Hold
- SLDB Strong Buy
- Analyst Count
- RXST 11
- SLDB 10
- Target Price
- RXST $11.80
- SLDB $15.00
- AVG Volume (30 Days)
- RXST 1.1M
- SLDB 752.0K
- Earning Date
- RXST 11-06-2025
- SLDB 11-05-2025
- Dividend Yield
- RXST N/A
- SLDB N/A
- EPS Growth
- RXST N/A
- SLDB N/A
- EPS
- RXST N/A
- SLDB N/A
- Revenue
- RXST $147,059,000.00
- SLDB N/A
- Revenue This Year
- RXST N/A
- SLDB N/A
- Revenue Next Year
- RXST $6.71
- SLDB N/A
- P/E Ratio
- RXST N/A
- SLDB N/A
- Revenue Growth
- RXST 27.68
- SLDB N/A
- 52 Week Low
- RXST $6.32
- SLDB $2.41
- 52 Week High
- RXST $57.53
- SLDB $8.10
- Technical
- Relative Strength Index (RSI)
- RXST 52.03
- SLDB 46.00
- Support Level
- RXST $9.10
- SLDB $4.87
- Resistance Level
- RXST $9.54
- SLDB $5.69
- Average True Range (ATR)
- RXST 0.50
- SLDB 0.30
- MACD
- RXST 0.03
- SLDB 0.01
- Stochastic Oscillator
- RXST 42.86
- SLDB 62.03
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.